Oncotarget and its Corresponding Fields of Research

Oncotarget is an open access medical journal that covers different aspects of oncology. It was first published in the year 2010 by the Impact Journals. It’s function is to publish papers online at a fee. Oncotarget’s mission is to come up with scientific results that are readily available. This is attained through intensive research to give room for further discovery. It is linked through their networks to different fields of study. Under the leadership of highly trained scientists, the journals aid researchers in contribution and the progress of science. The success of Oncotarget has led to the formation of sections beyond the field of oncology. Below are examples of further sections beyond oncology:

#1 Section on Pathology

Pathology section in Oncotarget was launched under the leadership of Michael Blagosklonny; who was the former Editor in Chief of American Journal of Pathology (AJP). The increasingly growing Oncotarget led to the formation of Pathology. There are several advantages of pathology section on Oncotarget as compared to ordinary pathology journals as shown below:

  • It has higher impact factor
  • Has relatively higher rapid publication
  • It is possible to submit papers rejected by other journal review platforms. Normally, it takes 1-5 days for the papers to be crosschecked.

#2 Sections on Aging (Gerotarget)

The section’s mandate is to publish high-end papers in different fields of researches related to; cellular senescence, pharmacological, signal transduction pathways, and genetics. The research also incorporates pathology model organisms in the treatment of age related diseases such as metabolic syndrome, hypertension, among others.

#3 Immunology and Microbiology Section

Success of Oncotarget has prompted the discovery of yet another section. The Immunology and Microbiology section deals in the publishing of papers in all areas in Oncotarget. Its specialty is research of cancer unrelated fields. Whereby, it incorporates the research of immunity cell development, antigen recognition, transplantation, clinical immunology, and mucosal immunology. Its submission is centralized via the Oncotarget systems. There are several advantages of this section as shown below:

  • Higher impact factor
  • Has relatively higher rapid publication
  • It is possible to communicate papers by the members of the Section Editorial Advisory Board

Leave a Reply

Your email address will not be published. Required fields are marked *